Departmental Publications

2014 Publications


  1. Singer N, Aina-Mumuney A, Poling J, Burton EC. Fetal death resulting from an isolated congenital partial pericardial defect. Obstet Gynecol 2014 Feb;123(2 Pt 2):443-6.


  1. Das S, Bedja D, Campbell N, Dunkerly B, Chenna V, Maitra A, Steenbergen C. miR-181c regulates the mitochondrial genome, bioenergetics, and propensity for heart failure in vivo. PLoS One. 2014 May 8;9(5):e96820.
  2. Ferlito M, Wang Q, Fulton WB, Colombani PM, Marchionni L, Fox-Talbot K, Paolocci N, Steenbergen C. H2S increases survival during sepsis: protective effect of CHOP inhibition. J Immunol 2014 Feb 15;192(4):1806-14.
  3. Haider BA, Baras AS, McCall MN, Hertel JA, Cornish TC, Halushka MK. A critical evaluation of microRNA biomarkers in non-neoplastic disease. PLoS One 2014 Feb 26;9(2):e89565.
  4. Huang HW, Cowan M, Matthews J, Lin MT, Milner S, Halushka M Fatal myocardial microabscesses caused by methicillin-resistant Staphylococcus aureus in a burn patient. Hum Pathol: Case Reprts 2014 Mar;1(1):10-2.
  5. Kent OA, McCall MN, Cornish TC, Halushka MK. Lessons from miR-143/145: the importance of cell-type localization of miRNAs. Nucl. Acids Res 2014 Jul;42(12):7528-38.
  6. Kohr MJ, Evangelista AM, Ferlito M, Steenbergen C, Murphy E. S-nitrosylation of TRIM72 at cysteine 144 is critical for protection against oxidation-induced protein degradation and cell death. J Mol Cell Cardiol. 2014 Apr;69:67-74.
  7. Kohr MJ, Murphy E, Steenbergen C. Glyceraldehyde-3-phosphate dehydrogenase acts as a mitochondrial trans-s-nitrosylase in the heart. PLoS One. 2014 Oct 27;9(10):e111448.
  8. Yano T, Ferlito M, Aponte A, Kuno A, Miura T, Murphy E, Steenbergen C. Pivotal role of mTORC2 and involvement of ribosomal protein S6 in cardioprotective signaling. Circ Res 2014 Apr 11;114(8):1268-80.
  9. Murphy E, Kohr M, Menazza S, Nguyen T, Evangelista A, Sun J, Steenbergen C. Signaling by S-nitrosylation in the heart. J Mol Cell Cardiol 2014 Aug;73C:18-25.


  1. Baycin-Hizal D, Wolozny D, Colao J, Jacobson E, Tian Y, Krag SS, Betenbaugh MJ, Zhang H. Glycoproteomic and glycomic databases. Clin Proteomics 2014 Apr;11(1):15.
  2. Clarke W. What is needed for optimal therapeutic drug monitoring? Bioanalysis. 2014 Jan;6(2):113-5.
  3. Crutchfield CA, Clarke W. Present and Future Applications of High Resolution Mass Spectrometry in the Clinic. Discoveries 2014 Apr-Jun;2(2):e17.
  4. Emory JF, Seserko LA, Marzinke MA. Development and bioanalytical validation of a liquid chromatographic-tandem mass spectrometric (LC-MS/MS) method for the quantification of the CCR5 antagonist maraviroc in human plasma. Clin Chim Acta 2014 Apr 20;431:198-205.
  5. Harlan R, Zhang H. Targeted proteomics: a bridge between discovery and validation. Expert Rev Proteomics. 2014 Dec;11(6):657-61.
  6. Henemyre-Harris CL, Samols M, Wenick AS, Sokoll LJ. Glow stick or urine sample? Clin Chem. 2014 Feb;60(2):425-6.
  7. Li D, Chan DW. Proteomic cancer biomarkers from discovery to approval: it's worth the effort. Expert Rev Proteomics 2014 Apr;11(2):135-6.
  8. Marzinke MA, Breaud A, Parsons TL, Cohen MS, Piwowar-Manning E, Eshleman SH, Clarke W. The development and validation of a method using high-resolution mass spectrometry (HRMS) for the qualitative detection of antiretroviral agents in human blood. Clin Chim Acta 2014 Jun 10;433:157-68.
  9. Marzinke MA, Clarke W, Wang L, Cummings V, Liu TY, Piwowar-Manning E, Breaud A, Griffith S, Buchbinder S, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Fields SD, Mayer KH, Wheeler DP, Koblin BA, Eshleman SH, Fogel JM. Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. Clin Infect Dis. 2014 Jan;58(1):117-20.
  10. Petrides AK, Clarke W, Marzinke MA. Application and utility of pharmacogenetics in the clinical laboratory. J Analyt Molecul Tech. 2014 Feb;1(1):15.
  11. Sartori DA, Chan DW. Biomarkers in prostate cancer: what's new? Curr Opin Oncol. 2014 May;26(3):259-64.
  12. Sun S, Zhou J, Yang W, and Zhang H*. Inhibition of protein carbamylation in urea solution using ammonium containing buffers. Anal Biochem 2014 Feb;446:76-81.
  13. Toghi Eshghi S, Yang S, Wang X, Shah P, Li X, Zhang H. Imaging of N-linked glycans from formalin-fixed paraffin-embedded tissue sections using MALDI mass spectrometry. ACS Chemical Biology 2014 Sept;9:2149-56.
  14. Wang X, Chen J, Li QK, Peskoe SB. Zhang B, Choi B, Platz EA, Zhang H. Overexpression of alpha (1,6) fucosyltransferase associated with aggressive prostate cancer. Glycobiology 2014 Oct;24(10):935-44.
  15. Yang W, Laeyendecker O, Wendel SK, Zhang B, Sun S, Zhou JY, Ao M, Moore RD, Jackson JB, Zhang H. Glycoproteomic study reveals altered plasma proteins associated with HIV elite suppressors. Theranostics. 2014 Sep;4(12):1153-63.
  16. Yang W, Shah P, Toghi Eshghi S, Yang S, Sun S. Ao M, Rubin A, Jackson, JB, Zhang H. Glycoform-analysis of recombinant and human deficiency virus envelope protein gp120 via higher energy C-trap dissociation and spectral-aligning strategy. Analytical Chemistry 2014 Jul;86:6959-67.
  17. Yang S, Zhang H. Glycomic analysis of glycans released from glycoproteins using chemical immobilization and mass spectrometry. Curr Protoc Chem Biol 2014 Sep 9;6(3):191-208.


  1. Ahmed A, Novak A, Farhat Sheerin A, Boonyaarunnate T, Ali S, Olson MT. Accuracy of cytotechnologist evaluation of specimen adequacy and screening interpretation of malignancy in fine-needle aspiration of the liver. Acta Cytologica 2014; 58:367-72.
  2. Ao MH, Zhang H, Sakowski L, Sharma R, Illei PB, Gabrielson E, Askin F, Li QK. The utility of a novel triple marker (combination of TTF1, napsin A, and p40) in the subclassification of non-small cell lung cancer. Hum Pathol 2014 May;45(5):926-34.
  3. Dudas R, Vandenbussche CV, Baras A, Ali SZ, Olson MT. Inexpensive telecytology solutions that use the raspberry Pi and iPhone. J Am Soc Cytopathol 2014 Jan;3:49-55.
  4. Guan H, Gurda G, Lennon MA, Hruban RH, Erozan YS. Intraductal tubulopapillary neoplasm of the pancreas on fine needle aspiration: case report with differential diagnosis. Diagn Cytopathol 2014 Feb;42(2):156-60.
  5. Holmes BJ, Sokoll LJ, Li QK. Measurement of fine-needle aspiration thyroglobulin levels increases the detection of metastatic papillary thyroid carcinoma in cystic neck lesions. Cancer Cytopathol July 2014;122(7):521-6.
  6. Mathur A, Najafian A, Schneider EB, Zeiger MA, Olson MT. Malignancy risk and reproducibility associated with atypia of undetermined significance on thyroid cytology. Surgery 2014 Dec;156(6):1471-6.
  7. Nauen D, Li QK. Cytological diagnosis of metastatic glioblastoma in the pleural effusion of a lung transplant patient. Diagn Cytopathol. 2014;42:619-23.
  8. Olson MT, Boonyaarunnate T, Aksoy Altinboga A, Ali SZ. 'Suspicious for a papillary thyroid carcinoma' before and after The Bethesda System for reporting thyroid cytopathology: Impact of standardized terminology. Acta Cytol 2014 Jan;58(1):15-22.
  9. Olson MT, Novak A, Boonyaarunnate T, Shahid H, Kirby J, Ali SZ. Cytotechnologist attended on-site evaluation of adequacy for bone and soft tissue fine needle aspiration. J Am Soc Cytopathol 2014 Mar; 3(2):60-6.
  10. Olson MT, Novak A, Trotter J, Sterling F, Kelly D, Sachs S, Cornish TC, Boonyaarunnate T, Toll A, Tatsas AD, Maleki Z, Erozan YS, Rosenthal DL. Reproducibility of The Johns Hopkins Hospital Template for Urologic Cytology Samples. J Am Soc Cytopathol 2014 May-June;3(3):156-64.
  11. Rodriguez E, Chen L, Ao MH1, Geddes S, Gabrielson E, Askin F, Zhang H, Li QK. Expression of transcript factors SALL4 and OCT4 in a subset of non-small cell lung carcinomas (NSCLC). Transl Respir Med 2014 Dec 2;2(1):10.
  12. Rooper LM, Ali SZ, Olson MT. A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: A retrospective analysis of 2540 cases. Cancer Cytopathol. 2014 Sep;122(9):657-65.
  13. Toll AD, Kelly D, Maleki Z. Utility of P16 expression and Ki-67 proliferation index in ASCUS and ASC-H pap tests. Diagnostic Cytopathol 2014 July;42(7):576-81.
  14. VandenBussche CJ, Adams C, Ali SZ, Olson MT. Cytotechnologist performance for detecting nuclear atypia in indeterminate thyroid fine needle aspirates. Acta Cytol. 2014;58(3):239-47.
  15. VandenBussche CJ, Ho CY, Nugent SL, Ali SZ. Extraneural metastases of primary central nervous system tumors identified by fine needle aspiration: a retrospective analysis. Acta Cytol 2014 Mar-Apr;58(2):117-24.
  16. VandenBussche CJ, Illei PB, Lin MT, Ettinger DS, Maleki Z. Molecular alterations in non-small cell lung carcinomas of the young. Hum Pathol. 2014 Dec;45(12):2379-87.
  17. VandenBussche CJ, Maleki Z. Fine-needle aspiration of squamous-lined cysts of the pancreas. Diagnostic Cytopathol 2014 July;42(7):592-9.
  18. VandenBussche CJ, Olson MT, Adams C, Ali SZ. Cytotechnologist performance for screening microfollicular atypia in indeterminate thyroid fine-needle aspirates. Acta Cytol. 2014;58(5):432-8.
  19. VandenBussche CJ, Wakely PE Jr, Siddiqui MT, Maleki Z, Ali SZ. Cytopathologic characteristics of epithelioid vascular malignancies. Acta Cytol. 2014;58(4):356-66.


  1. Ali MA, Arnold CA, Singhi AD, Voltaggio L. Clues to uncommon and easily overlooked infectious diagnoses affecting the GI tract and distinction from their clinicopathologic mimics. Gastrointest Endosc. 2014 Oct;80(4):689-706.
  2. Chen G, Mosier S, Gocke CD, Lin MT, Eshleman JR. Cytosine deamination is a major cause of baseline noise in next-generation sequencing. Mol Diagn Ther 2014 Oct;18(5):587-93.
  3. Debeljak M, Freed DN, Welch JA, Haley L, Beierl K, Iglehart BS, Pallavajjala A, Gocke CD, Leffell MS, Lin MT, Pevsner J, Wheelan SJ, Eshleman JR. Haplotype counting by next-generation sequencing for ultrasensitive human DNA detection. J Molec Diagn 2014 Sept;16(5):495-503.
  4. Gurda GT, Zhu Q, Bai H, Pan D, Schwarz KB, Anders RA. The use of Yes-associated protein expression in the diagnosis of persistent neonatal cholestatic liver disease. Hum Pathol. 2014 May;45(5):1057-64.
  5. Jiao Y, Yonescu R, Offerhaus GJ, Klimstra DS, Maitra A, Eshleman JR, Herman JG, Poh W, Pelosof L, Wolfgang CL, Vogelstein B, Kinzler KW, Hruban RH, Papadopoulos N, Wood LD. Whole-exome sequencing of pancreatic neoplasms with acinar differentiation. J Pathol 2014 Mar;232(4):428-35.
  6. Kim H, Saka B, Knight S, Borges M, Childs E, Klein AP, Wolfgang CL, Herman JM, Adsay V, Hruban RH, Goggins M. Having pancreatic cancer with tumoral loss of ATM and normal TP53 protein expression is associated with a poorer prognosis. Clin Cancer Res 2014 Apr 1;20(7):1865-72.
  7. Le A, Stine ZE, Nguyen C, Afzal J, Sun P, Hamaker M, Siegel NM, Gouw AM, Kang BH, Yu SH, Cochran RL, Sailor KA, Song H, Dang CV. Tumorigenicity of hypoxic respiring cancer cells revealed by a hypoxia-cell cycle dual reporter. Proc Natl Acad Sci U S A. 2014;111(34):12486-91.
  8. Lennon AM, Wolfgang CL, Canto EK, Kamel I, Weiss MJ, Diaz LA, Papdopoulos N, Kinzler KW, Vogelstein B, Hruban RH. The early detection of pancreatic cancer: what will it take to diagnose and treat curable pancreatic neoplasia? Cancer Res July 2014;74:3381.
  9. Lin MT, Mosier SL, Thiess M, Beierl KF, Debeljak M, Tseng LH, Chen G, Yegnasubramanian S, Ho H, Cope L, Wheelan SJ, Gocke CD, Eshleman JR. Clinical Validation of KRAS, BRAF and EGFR Mutation Detection using Next Generation Sequencing. Am J Clin Pathol 2014 June;141(6):856-66.
  10. Ma C, Giardiello FM, Montgomery EA. Upper tract juvenile polyps in juvenile polyposis patients: dysplasia and malignancy are associated with foveolar, intestinal, and pyloric differentiation. Am J Surg Pathol 2014 Dec;38(12):1618-26.
  11. Ma C, Limketkai BN, Montgomery EA. Recently highlighted non-neoplastic pathologic entities of the upper GI tract and their clinical significance. Gastrointest Endosc. 2014 Dec;80(6):960-9.
  12. Matthaei H, Wu J, Dal Molin M, Shi C, Perner S, Kristiansen G, Lingohr P, Kalff JC, Wolfgang CL, Kinzler KW, Vogelstein B, Maitra A, Hruban RH. GNAS Sequencing Identifies IPMN-specific Mutations in a Subgroup of Diminutive Pancreatic Cysts Referred to as "Incipient IPMNs". Am J Surg Pathol 2014 Mar;38(3):360-3.
  13. McCall CM, Mosier S, Thiess M, Debeljak M, Pallavajjala A, Beierl K, Deak KL, Datto MB, Gocke CD, Lin MT, Eshleman JR. False positives in multiplex PCR-based next-generation sequencing have unique signatures. J Mol Diagn 2014 Sep;16(5):541-9.
  14. Montgomery E, Voltaggio L. Mesenchymal polyps. Diagn Histopathol 2014 Jan;20(1):19-29.
  15. Montgomery E, Voltaggio L, Vieth M. Inflammation, malignancy and immunology in gastrointestinal spindle cell tumors: what is beyond GIST?. Pathologe. 2014 Nov;35 Suppl 2:207-13.
  16. Piwowar-Manning E, Fogel JM, Laeyendecker O, Wolf S, Cummings V, Marzinke M, Clarke W, Breaud A, Wendel S, Wang L, Swanson P, Hackett J, Jr., Mannheimer S, del Rio C, Kuo I, Harawa NT, Koblin BA, Matthaei H, Wu J, dal Molin M, Shi C, Perner S, Kristiansen G, Lingohr P, Klaff JC, Wolfgang CL, Kinzler KW, Vogelstein B, Maitra A, Hruban RH. GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "Incipient IPMNs." Am J Surg Pathol 2014 Mar;38(3):360-3.
  17. Rodriguez E, Tellschow S, Steinberg DM, Montgomery E. Cytologic findings of gastric schwannoma: a case report. Diagn Cytopathol 2014 Feb;42(2):177-80.
  18. Sadakari Y, Kanda M, Maitani K, Borges M, Canto MI, Goggins M. Mutant KRAS and GNAS DNA concentrations in secretin-stimulated pancreatic fluid collected from the pancreatic duct and the duodenal lumen. Clin Transl Gastroenterol 2014 Nov;5:e62.
  19. Singhi AD, Arnold CA, Crowder CD, Lam-Himlin DM, Voltaggio L, Montgomery EA. Esophageal leukoplakia or epidermoid metaplasia: a clinicopathological study of 18 patients. Modern Pathol 2014 Jan;27:38-43.
  20. Slavik T, Montgomery EA. Cronkhite-Canada syndrome six decades on: the many faces of an enigmatic disease. J Clin Pathol. 2014 Oct;67(10):891-7.
  21. Taube JM, Klein A, Brahmer JR, Xu H, Pan X, Kim JH, Chen L, Pardoll DM, Topalian SL, Anders RA. Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy. Clin Cancer Res Oct 2014;20:5064.
  22. Vieth M, Montgomery EA. Some observations on pyloric gland adenoma: an uncommon and long ignored entity! J Clin Pathol. 2014 Oct;67(10):883-90.
  23. Vieth M, Riddell RH, Montgomery EA. High-grade dysplasia versus carcinoma: east is east and west is west, but does it need to be that way? Am J Surg Pathol 2014 Nov;38(11):1453-6.
  24. Vincent A, Hong SM, Hu C, Omura N, Young A, Kim H, Yu J, Knight S, Ayars M, Griffith M, Van Seuningen I, Maitra A, Goggins M. Epigenetic silencing of EYA2 in pancreatic adenocarcinomas promotes tumor growth. Oncotarget. 2014 May 15;5(9):2575-87.
  25. Voltaggio L, Lam-Himlin D, Limketkai BN, Singhi AD, Arnold CA. Message in a bottle: decoding medication injury patterns in the gastrointestinal tract. J Clin Pathol 2014 Oct;67(10):903-12.
  26. Voltaggio L, Montgomery E. Gastric mesenchymal lesions other than gastrointestinal stromal tumor. Diagn Histopathol 2014 June;20(6):228-38.
  27. Wood LD. Update on Colorectal Polyps and Polyposis Syndromes. Diagn Histopathol. 2014 Jan;20:12-8.
  28. Wood LD, Klimstra DS. Pathology and genetics of pancreatic neoplasms with acinar differentiation. Semin Diagn Pathol. 2014 Nov;31(6):491-7.
  29. Wood LD, Salaria SN, Cruise MW, Giardiello FM, Montgomery EA. Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms. Am J Surg Pathol 2014 Mar;38(3):389-93.


  1. Amin MB, Epstein JI*, et al; Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group. Best practices recommendations in the application of immunohistochemistry in urologic pathology: report from the International Society of Urological Pathology consensus conference. Am J Surg Pathol. 2014 Aug;38(8):1017-22.
  2. Bagnasco SM, Gottipati S, Kraus E, Alachkar N, Montgomery RA, Racusen LC, Arend LJ. Sarcoidosis in native and transplanted kidneys: incidence, pathologic findings, and clinical course. PLoS One. 2014 Oct 20;9(10):e110778.
  3. Bagnasco SM, Zachary AA, Racusen LC, Arend LJ, Carter-Monroe N, Alachkar N, Nazarian SM, Lonze BE, Montgomery RA, Kraus ES. Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients. Transplantation 2014 Feb 27;97(4):440-5.
  4. Berman DM, Epstein JI. When is prostate cancer really cancer? Urol Clinic N Amer 2014 May;41:339-46.
  5. Bezerra SM, Lotan TL, Faraj SF, Karram S, Sharma R, Schoenberg M, Bivalacqua TJ, Netto GJ. GATA3 expression in small cell carcinoma of bladder and prostate and its potential role in determining primary tumor origin. Hum Pathol 2014 Aug;45(8):1682-7.
  6. Chaux A, Cubilla AL, Haffner MC, Lecksell KL, Sharma R, Burnett AL, Netto GJ. Combining routine morphology, p16INK4a immunohistochemistry, and in situ hybridization for the detection of human papillomavirus infection in penile carcinomas: A tissue microarray study using classifier performance analyses. Urol Oncol 2014 Feb;32(2):171-7.
  7. Chaux A, Munari E, Cubilla AL, Hicks J, Lecksell K, Burnett AL, Netto GJ. Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a tissue microarray study of 112 cases. Histopathology 2014 May;64(6):863-71.
  8. Cox R, Vang R, Epstein JI. Papillary cystadenoma of the epididymis and broad ligament: Morphological and immunohistochemical overlap with clear cell papillary renal cell carcinoma. Am J Surg Pathol 2014 May 2014;38:713-8.
  9. Darshan M, Zheng Q, Fedor HL, Wyhs N, Yegnasubramanian S, Lee P, Melamed J, Netto GJ, Trock BJ, De Marzo AM, Sfanos KS. Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network. Prostate 2014 Jan;74(1):61-9.
  10. Epstein JI, Amin MB, Beltran H, Lotan TL, Mosquera JM, Reuter VE, Robinson BD, Troncoso P, Rubin MA. Proposed morphologic classification of prostate cancer with neuroendocrine differentiation. Am J Surg Pathol 2014 Jun;38(6):756-67.
  11. Epstein JI, Egevad L, Humphrey PA, Montironi R; Members of the ISUP Immunohistochemistry in Diagnostic Urologic Pathology Group. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference. Am J Surg Pathol 2014 Aug;38(8):e6-e19.
  12. Faraj SF, Chaux A, Gonzalez-Roibon N, Munari E, Ellis C, Driscoll T, Schoenberg MP, Bivalacqua TJ, Shih IM, Netto GJ. ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder. Hum Pathol 2014 Nov;45(11):2233-9.
  13. Gonzalez-Roibon N, Kim JJ, Faraj SF, Chaux A, Bezerra SM, Munari E, Ellis C, Sharma R, Keizman D, Bivalacqua TJ, Schoenberg M, Eisenberger M, Carducci M, Netto GJ. Insulin-like growth factor-1 receptor overexpression is associated with outcome in invasive urothelial carcinoma of urinary bladder: a retrospective study of patients treated using radical cystectomy. Urology 2014 Jun;83(6):1444.e1-6.
  14. Gordetsky, J, Bivalacqua T, Schoenberg M, Epstein JI. Ureteral and urethral frozen sections during radical cystectomy/cystoprostatectomy: an analysis of denudation and atypia. Urology 2014 Sep;84(3):619-23.
  15. Gordetsky J, Epstein JI. Pseudopapillary features in prostatic adenocarcinoma mimicking urothelial carcinoma: a diagnostic pitfall. Am J Surg Pathol 2014 Jul;38(7):941-5.
  16. Gurda GT, Vandenbussche CJ, Yonescu R, Gonzalez-Roibon N, Ellis CL, Batista DA, Netto GJ. Sacrococcygeal teratomas: clinico-pathological characteristics and isochromosome 12p status. Mod Pathol 2014 Apr;27(4):562-8.
  17. Gurel B, Lucia MS, Thompson IM Jr, Goodman PJ, Tangen CM, Kristal AR, Parnes HL, Hoque A, Lippman SM, Sutcliffe S, Peskoe SB, Drake CG, Nelson WG, De Marzo AM, Platz EA. Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2014 May;23(5):847-56.
  18. Hurwitz LM, Heaphy CM, Joshu CE, Isaacs WB, Konishi Y, De Marzo AM, Isaacs SD, Wiley KE, Platz EA, Meeker AK. Telomere length as a risk factor for hereditary prostate cancer. Prostate 2014 Apr;74(4):359-64.
  19. Ishiguro H, Kawahara T, Zheng Y, Kashiwagi E, Li Y, Miyamoto H. Differential regulation of bladder cancer growth by various glucocorticoids: corticosterone and prednisone inhibit cell invasion without promoting cell proliferation or reducing cisplatin cytotoxicity. Cancer Chemother Pharmacol 2014 Aug;74(2):249-55.
  20. Ishiguro H, Kawahara T, Zheng Y, Netto GJ, Miyamoto H. Reduced glucocorticoid receptor expression predicts bladder tumor recurrence and progression. Am J Clin Pathol 2014 Aug;142(2):157-64.
  21. Izumi K, Li Y, Ishiguro H, Zheng Y, Yao JL, Netto GJ, Miyamoto H. Expression of UDP-glucuronosyltransferase 1A in bladder cancer: association with prognosis and regulation by estrogen. Mol Carcinog 2014 Apr;53(4):314-24.
  22. Karram S, Kao CS, Osunkoya AO, Ulbright TM, Epstein JI. Idiopathic granulomatous orchitis: morphology and evaluation of its relationship to IgG4 related disease. Hum Pathol 2014 Apr;45(4):844-50.
  23. Kawahara T, Miyamoto H. Androgen receptor antagonists in the treatment of prostate cancer. Clin Immunol Endocr Metab Drugs 2014 Jun;1(1):11-9.
  24. Kryvenko ON, Carter HB, Trock BJ, Epstein JI. Biopsy criteria for determining appropriateness for active surveillance in the modern era. Urology 2014 Apr;83(4):869-74.
  25. Kryvenko ON, Jorda M, Argani P, Epstein JI. Diagnostic approach to eosinophilic renal neoplasms. Arch Pathol Lab Med 2014 Nov;138(11):1531-41
  26. Lee SL, Illei PB, Han JS, Epstein JI. Florid mesothelial hyperplasia of the tunica vaginalis mimicking malignant mesothelioma: A clinicopathologic study of 12 cases. Am J Surg Pathol 2014 Jan;38(1):54-9.
  27. Li Y, Ishiguro H, Kawahara T, Kashiwagi E, Izumi K, Miyamoto H. Loss of GATA3 in bladder cancer promotes cell migration and invasion. Cancer Biol Ther. 2014 Apr 1;15(4):428-35.
  28. Li Y, Ishiguro H, Kawahara T, Miyamoto Y, Izumi K, Miyamoto H. GATA3 in the urinary bladder: suppression of neoplastic transformation and down-regulation by androgens. Am J Cancer Res. 2014 Sep 6;4(5):461-73.
  29. Matoso A, Chen S, Plaza JA, Osunkoya AO, Epstein JI. Symplastic leiomyomas of the scrotum: a comparative study to usual leiomyomas and leiomyosarcomas. Am J Surg Pathol. 2014 Oct;38(10):1410-7.
  30. Matoso A, Ross HM, Chen S, Allbritton J, Epstein JI. Squamous neoplasia of the scrotum: a series of 29 cases. Am J Surg Pathol. 2014 Jul;38(7):973-81.
  31. Munari E, Marchionni L, Chitre A, Hayashi M, Martignoni G, Brunelli M, Gobbo S, Argani P, Allaf M, Hoque MO, Netto GJ. Clear cell papillary renal cell carcinoma: micro-RNA expression profiling and comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma. Hum Pathol 2014 Jun;45(6):1130-8.
  32. Nie X, Arend LJ. Novel roles of Pkd2 in male reproductive system development. Differentiation 2014 Mar-Apr;87(3-4):161-71.
  33. Partin AW, Van Neste L, Klein EA, Marks LS, Gee JR, Troyer DA, Rieger-Christ K, Jones JS, Magi-Galluzzi C3, Mangold LA, Trock BJ, Lance RS, Bigley JW, Van Criekinge W, Epstein JI. Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies. J Urol 2014 Oct;192(4):1081-7.
  34. Sfanos KS, Hempel HA, De Marzo AM. The role of inflammation in prostate cancer. Adv Exp Med Biol 2014;816:153-81.
  35. So JS, Epstein JI. Histologic features of pseudohyperplastic perineural invasion in prostatic adenocarcinoma: A mimicker of benign hyperplastic glands and high grade prostatic intraepithelial neoplasia. Am J Surg Pathol 2014 Jun;38(6):852-7.
  36. So J, Epstein JI. Variant of prostatic adenocarcinoma with paneth cell-like neuroendocrine differentiation readily misdiagnosed as gleason pattern 5. Hum Pathol 2014 Dec;45:2388-93.
  37. Tan HL, Sood A, Rahimi HA, Wang W, Gupta N, Hicks J, Mosier S, Gocke CD, Epstein JI, Netto GJ, Liu W, Isaacs WB, De Marzo AM, Lotan TL. Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma. Clin Cancer Res 2014 Feb 15;20(4):890-903.
  38. Tian W, Latour M, Epstein JI. Endometrial stromal sarcoma involving the urinary bladder: a study of 6 cases. Am J Surg Pathol 2014 Jul;38(7):982-9.
  39. Wang CC, Al-Hussain TO, Epstein JI. Rosai-Dorfman disease (RDD) of the testis and kidney: Analysis of 5 cases. Histopathology 2014 Dec;65:908-16.
  40. Wang C, Carter HC, Epstein JI. Value of transition zone biopsy in active surveillance of prostate cancer. J Urol 2014 June;191(6):1755-9.
  41. Zhang M, Wah C, Epstein JI. Metastatic renal cell carcinoma to the urinary bladder: a report of 11 cases. Am J Surg Pathol. 2014 Nov;38(11):1516-21.


  1. Ardighieri L, Zeppernick F, Hannibal CG, Vang R, Cope L, Junge J, Kjaer SK, Kurman RJ, Shih IeM. Mutational analysis of BRAF and KRAS in ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants. J Pathol 2014 Jan;232(1):16-22.
  2. Banet N, Descipio C, Murphy KM, Beierl K, Adams E, Vang R, Ronnett BM. Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping. Mod Pathol. 2014 Feb;27(2):238-54.
  3. Davidson B, Abeler VM, Fâ”ÂÂÂÂÂœĚžrsund M, Holth A, Yang Y, Kobayashi Y, Chen L, Kristensen GB, Shih IeM, Wang TL. Gene expression signatures of primary and metastatic uterine leiomyosarcoma. Hum Pathol 2014 Apr;45(4):691-700.
  4. Elwood H, Kim J, Yemelyanova A, Ronnett BM, Taube JM. Basal cell carcinomas of the vulva: high-risk human papillomavirus DNA detection, p16 and BerEP4 expression. Am J Surg Pathol 2014 Apr;38(4):542-7.
  5. Gao M, Wu RC, Herlinger AL, Yap K, Kim JW, Wang TL, Shih IeM. Identification of the NAC1-regulated genes in ovarian cancer. Am J Pathol 2014 Jan;184(1):133-40.
  6. Guan B, Suryo Rahmanto Y, Wu RC, Wang Y, Wang Z, Wang TL, Shih IeM. Roles of deletion of arid1a, a tumor suppressor, in mouse ovarian tumorigenesis. J Natl Cancer Inst 2014 July;106(7):dju146.
  7. Guan B, Wu RC, Zhu H, Blackshaw S, Shih IeM, Wang TL. Notch3 interactome analysis identified WWP2 as a negative regulator of notch3 signaling in ovarian cancer. PLoS Genet 2014 Oct;10(10):e1004751.
  8. Gunderson CC, Dutta S, Fader AN, Maniar KP, Nasseri-Nik N, Bristow RE, Diaz-Montes TP, Palermo R, Kurman RJ. Pathologic features associated with resolution of complex atypical hyperplasia and grade 1 endometrial adenocarcinoma after progestin therapy. Gynecol Oncol 2014 Jan;132(1):33-7.
  9. Gurda GT, Baras AS, Kurman RJ. Ki-67 index as an ancillary tool in the differential diagnosis of proliferative endometrial lesions with secretory change. Int J Gynecol Pathol 2014 Mar;33(2):114-9.
  10. Jung JG, Stoeck A, Guan B, Wu RC, Zhu H, Blackshaw S, Shih IeM, Wang TL. Notch3 Interactome Analysis Identified WWP2 as a Negative Regulator of Notch3 Signaling in Ovarian Cancer. PLoS Genet 2014 Oct 30;10(10):e1004751.
  11. Kang TH, Knoff J, Yeh WH, Yang B, Wang C, Kim YS, Kim TW, Wu TC, Hung CF. Treatment of tumors with vitamin E suppresses myeloid derived suppressor cells and enhances CD8+ T cell-mediated antitumor effects. PLoS One. 2014 Jul 29;9(7):e103562.
  12. Knoff J, Yang B, Hung CF, Wu TC. Cervical cancer: development of targeted therapies beyond molecular pathogenesis. Curr Obstet Gynecol Rep 2014 Mar 1;3(1):18-32.
  13. Kuhn E, Ayhan A, Shih IeM, Seidman JD, Kurman RJ. The pathogenesis of atypical proliferative Brenner tumor: an immunohistochemical and molecular genetic analysis. Mod Pathol 2014 Feb;27(2):231-7.
  14. Kurman RJ, Shih IeM. Discovery of a cell: reflections on the checkered history of intermediate trophoblast and update on its nature and pathologic manifestations. Int J Gynecol Pathol. 2014 Jul;33(4):339-47.
  15. Maniar KP, Wang Y, Visvanathan K, Shih IM, Kurman RJ. Evaluation of microinvasion and lymph node involvement in ovarian serous borderline/atypical proliferative serous tumors: a morphologic and immunohistochemical analysis of 37 cases. Am J Surg Pathol. 2014 Jun;38(6):743-55.
  16. Nik NN, Vang R, Shih IeM, Kurman RJ. Origin and pathogenesis of pelvic (ovarian, tubal and primary peritoneal) serous carcinoma. Annu Rev Pathol 2014 Jan 24;9:27-45.
  17. Peng S, Song L, Knoff J, Wang JW, Chang YN, Hannaman D, Wu TC, Alvarez RD, Roden RB, Hung CF. Control of HPV-associated tumors by innovative therapeutic HPV DNA vaccine in the absence of CD4+ T cells. Cell Biosci. 2014 Mar 4;4(1):11.
  18. Song L, Yang MC, Knoff J, Sun ZY, Wu TC, Hung CF. Cancer immunotherapy using a potent immunodominant CTL epitope. Vaccine. 2014 Oct;32(46):6039-48.
  19. Song L, Yang MC, Knoff J, Wu TC, Hung CF. Cancer immunotherapy employing an innovative strategy to enhance CD4+ T cell help in the tumor microenvironment. PLoS One. 2014 Dec;9(12):e115711.
  20. Soong RS, Song L, Trieu J, Knoff J, He L, Tsai YC, Huh W, Chang YN, Cheng WF, Roden RB, Wu TC, Trimble CL, Hung CF. Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract Leading to tumor control through IFNâ•̚│. Clin Cancer Res. 2014 Nov 1;20(21):5456-67.
  21. Soong RS, Song L, Trieu J, Lee SY, He L, Tsai YC, Wu TC, Hung CF. Direct T cell activation via CD40 ligand generates high avidity CD8+ T cells capable of breaking immunological tolerance for the control of tumors. PLoS One. 2014 Mar 24;9(3):e93162.
  22. Wang JW, Jagu S, Kwak K, Wang C, Peng S, Kirnbauer R, Roden RB. Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studies. Virology 2014 Jan 20;449:304-16.
  23. Wu CY, Yang LH, Yang HY, Knoff J, Peng S, Lin YH, Wang C, Alvarez RD, Pai SI, Roden RB, Hung CF, Wu TC. Enhanced cancer radiotherapy through immunosuppressive stromal cell destruction in tumors. Clin Cancer Res. 2014 Feb 1;20(3):644-57.
  24. Wu RC, Ayhan A, Maeda D, Kim KR, Clarke BA, Shaw P, Chui MH, Rosen B, Shih IeM, Wang TL. Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy. J Pathol 2014 Mar;232(4):473-81.
  25. Wu RC, Wang TL, Shih IeM. The emerging roles of ARID1A in tumor suppression. Cancer Biol Ther. 2014 Jun;15(6):655-64.
  26. Yang B, Jeang J, Yang A, Wu TC, Hung CF. DNA vaccine for cancer immunotherapy. Hum Vaccin Immunother. 2014;10(11):3153-64.
  27. Yeh CT, Liang KH, Lin CC, Chang ML, Hsu CL, Hung CF. A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma. Int J Cancer 2014 Mar 1;134(5):1214-24.
  28. Yemelyanova A, Gown AM, Wu LS, Holmes BJ, Ronnett BM, Vang R. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations. Int J Gynecol Pathol 2014 Sep;33(5):492-9.


  1. Borowitz MJ. Mixed phenotype acute leukemia. Cytometry B Clin Cytom. 2014 May;86(3):152-3.
  2. Crane GM, Ambinder RF, Shirley CM, Fishman EK, Kasamon YL, Taube JM, Borowitz MJ, Duffield AS. HHV-8-positive and EBV-positive intravascular lymphoma: an unusual presentation of extracavitary primary effusion lymphoma. Am J Surg Pathol 2014 Mar;38(3):426-32.
  3. Crane GM, Xian RR, Burns KH, Borowitz MJ, Duffield AS, Taube JM. Primary effusion lymphoma presenting as a cutaneous intravascular lymphoma. J Cutan Pathol 2014 Dec;41(12):928-35.
  4. Monroe AK, Butler NJ, Duffield AS. Sclerouveitis associated with Rosai-Dorfman Disease in an HIV-infected patient. Ocul Immunol Inflamm 2014 Jun;22(3):236-8.
  5. Rodić N, Sharma R, Sharma R, Zampella J, Dai L, Taylor MS, Hruban RH, Iacobuzio-Donahue CA, Maitra A, Torbenson MS, Goggins M, Shih IM, Duffield AS, Montgomery EA, Gabrielson E, Netto GJ, Lotan TL, De Marzo AM, Westra W, Binder ZA, Orr BA, Gallia GL, Eberhart CG, Boeke JD, Harris CR, Burns KH. Long interspersed element-1 protein expression is a hallmark of many human cancers. Am J Pathol 2014 May;184(5):1280-6.


  1. Caturegli P, De Remigis A, Rose NR.Hashimoto thyroiditis: Clinical and diagnostic criteria. Autoimmun Rev. 2014 Apr-May;13(4-5):391-7
  2. Chin MS, Hooper LC, Hooks JJ, Detrick B. Identification of ∝-fodrin as an autoantigen in experimental coronavirus retinopathy (ECOR). J Neuroimmunol 2014 Jul 15;272(1-2):42-50.
  3. Chiu YL, Shan L, Huang H, Haupt C, Bessell C, Canaday DH, Zhang H, Ho YC, Powell JD, Oelke M, Margolick JB, Blankson JN, Griffin DE, Schneck JP. Sprouty-2 regulates HIV-specific T cell polyfunctionality. J Clin Invest 2014 Jan 2;124(1):198-208.
  4. Gocke CD. c-Myc immunohistochemistry in diffuse large B cell lymphoma. Pathol Case Revs 2014 Sept/Oct;19(5):234-8.
  5. Grunwald MR, Tseng LH, Lin MT, Pratz KW, Eshleman JR, Levis MJ, Gocke CD. Improved FLT3 internal tandem duplication PCR assay predicts outcome after allogeneic transplant for acute myeloid leukemia. Biol Blood Marrow Transplant. 2014 Dec;20(12):1989-95.
  6. Iwama S, De Remigis A, Callahan MK, Slovin SF, Wolchok JD, Caturegli P. Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody. Sci Transl Med 2014 Apr;6(230):230ra45.
  7. Karafin MS, Humphrey RL, Detrick B. Evaluation of monoclonal and oligoclonal gammopathies in a pediatric population in a major urban center. Am J Clin Pathol. 2014 Apr;141(4):482-7.
  8. Kim A, Hartman IZ, Poore B, Boronina T, Cole RN, Song N, Ciudad MT, Caspi RR, Jaraquemada D, Sadegh-Nasseri S. Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources. Nat Commun 2014 Nov;5:5369.
  9. Nagineni CN, Raju R, Nagineni KK, Kommineni VK, Cherukuri A, Kutty RK, Hooks JJ, Detrick B. Resveratrol suppresses expression of VEGF by human retinal pigment epithelial cells: potential nutraceutical for age-related macular degeneration. Aging Dis 2014 Apr;5(2):88-100.
  10. Outschoorn IM, Talor MV, Burek CL, Hoffman WH, Rose NR. Heritability analysis of IgG4 antibodies in autoimmune thyroid disease. Autoimmunity 2014 Aug;47(5):320-6.
  11. Perez-Munoz ME, Bergstrom K, Peng V, Schmaltz R, Jimenez-Cardona R, Marsteller N, McGee S, Clavel T, Ley R, Xia L, Peterson DA. Discordance between changes in the gut microbiota and pathogenicity in a mouse model of spontaneous colitis. Gut Microbes. 2014 May;5(3):286-95.
  12. Perica K, Medero ADL, Malarvizhi D, Chiu Y-L, Bieler JG, Niemöller M, Assenmacher M, Richter A, Edidin M, Oelke M, Schneck JP. Nanoscale artificial antigen presenting cells for T cell immunotherapy. Nanomedicine 2014 Jan;10(1):119-29.
  13. Perica K, Tu A, Richter A, Bieler JG, Edidin M, Schneck JP. Magnetic field-induced T cell receptor clustering by nanoparticles enhances T cell activation and stimulates antitumor activity. ACS Nano.2014 Mar 25;8(3):2252-60.
  14. Rose NR. Learning from myocarditis: mimicry, chaos and black holes. F1000Prime Rep. 2014 May;6:25.
  15. Schroeder LF, Amukele T. Medical laboratories in sub-Saharan Africa that meet international quality standards. Am J Clin Pathol 2014 Jun;141(6):791-5.
  16. Schütz C, Fleck M, Schneck JP, Oelke M. Killer artificial antigen presenting cells (KaAPC) for efficient in vitro depletion of human antigen-specific T cells. J Vis Exp 2014 Aug 11;(90).
  17. Sunshine JC, Perica K, Schneck JP, Green JJ. Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells. Biomaterials 2014 Jan;35(1):269-77.
  18. Wu L, Ong S, Talor MV, Barin JG, Baldeviano GC, Kass DA, Bedja D, Zhang H, Sheikh A, Margolick JB, Iwakura Y, Rose NR, Čiháková D. Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy. J Exp Med 2014 Jun;211(7):1449-64.


None reported.


  1. Kuo IC, Espinosa C, Forman M, Pehar M, Maragakis LL, Valsamakis A. Detection and prevalence of adenoviral conjunctivitis among hospital employees using real-time polymerase chain reaction as an infection prevention tool. Infect Control Hosp Epidemiol. 2014 Jun;35(6):728-31.
  2. Fowler MG, Coovadia H, Herron CM, Maldonado Y, Chipato T, Moodley D, Musoke P, Aizire J, Manji K, Stranix-Chibanda L, Fawzi W, Chetty V, Msweli L, Kisenge R, Brown E, Mwatha A, Eshleman SH, Richardson P, Allen M, George K, Andrew P, Zwerski S, Mofenson LM, Jackson JB; HPTN 046 Protocol Team. Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial. J Acquir Immune Defic Syndr. 2014 Mar 1;65(3):366-74.
  3. Liu CM, Osborne BJ, Hungate BA, Shahabi K, Huibner S, Lester R, Dwan MG, Kovacs C, Contente-Cuomo TL, Benko E, Aziz M, Price LB, Kaul R. The semen microbiome and its relationship with local immunology and viral load in HIV infection. PLoS Pathog 2014 Jul 24;10(7):e1004262.
  4. Matovu JN, Onyango-Makumbi C, Namuli PE, Tanga EO, Kagawa MN, Nalwadda GK, Motevalli M, Semitala FC, O'Gara ET, Fowler MG. WHO 2010 infant feeding guidelines in resource-limited settings: attitudes of human immunodeficiency virus-infected women and other role players in Kampala, Uganda. S African J of Clin Nutrition Apr 2014;27(2):63-8.
  5. Riedel S. The value of postmortem microbiology cultures. J Clin Microbiol 2014 Apr;52(4):1028-33.
  6. Riedel S, Neoh KM, Eisinger SW, Dam LM, Tekle T, Carroll KC. Comparison of commercial antimicrobial susceptibility test methods for testing of Staphylococcus aureus and Enterococci against vancomycin, daptomycin, and linezolid. J Clin Microbiol 2014 June;52(6):2216-22.
  7. Salimnia H, Fairfax MR, Lephart P, Morgan M, Gilbreath JJ, Butler-Wu SM, Templeton KE, Hamilton FJ, Wu F, Buckner R, Fuller D, Davis TE, Abdelhamed AM, Jacobs MR, Miller A, Pfrommer B, Carroll KC. An international, prospective, multicenter evaluation of the combination of AdvanDx Staphylococcus QuickFISH BC with mecA XpressFISH for detection of methicillin-resistant Staphylococcus aureus isolates from positive blood cultures. J Clin Microbiol 2014 Nov;52(11):3928-32.
  8. Schieffer KM, Tan KE, Stamper PD, Somogyi A, Andrea SB, Wakefield T, Romagnoli M, Chapin KC, Wolk DM, Carroll KC. Multicenter evaluation of the SepsityperTM extraction kit and MALDI-TOF MS for direct identification of positive blood culture isolates using the BD BACTECTM FX and VersaTREK(®) diagnostic blood culture systems. J Appl Microbiol 2014 Apr;116(4):934-41.
  9. Sue PK, Gurda GT, Richard Lee R, Watkins T, Green R, Memon W, Milstone AM, Zelazny AM, Fahle GA, Pham TA, Gibas CF, Sutton DA, Wickes BL, Wiederhold NP, Zhang SX. First report of Westerdykella dispersa as a cause of an angioinvasive fungal infection in a neutropenic host. J Clin Microbiol 2014 Dec;52(12):4407-11.
  10. Suwantarat N, Carroll KC, Tekle T, Ross T, Maragakis LL, Cosgrove SE, Milstone AM. High prevalence of reduced chlorhexidine susceptibility in organisms causing central line associated blood stream infections. Infect Control Hosp Epidemiol. 2014 Sep;35(9):1183-6.
  11. Suwantarat N, Lee R, Carroll KC, Zhang SX. Questionable utility of galactomannan testing for diagnosis of Exserohilum rostratum infection. J Clin Microbiol 2014 Jul;52(7):2742-3.
  12. Suwantarat N, Roberts A, Prestridge J, Seeley R, Speser S, Harmon C, Zhang C, Henciak S, Stamper PD, Ross T, Carroll KC. Comparison of five chromogenic media for recovery of vancomycin-resistant enterococci from fecal samples. J Clin Microbiol 2014 Nov;52:4039-42
  13. Suwantarat N, Romagnoli M, Wakefield T, Carroll KC. Ventriculoperitoneal shunt infection caused by Bifidobacterium breve. Anaerobe 2014 Aug;28:1-3.
  14. Suwantarat N, Watkins T, Lee R, Carroll KC, Zhang SX. False positive reaction of L-canavanine glycine bromothymol blue medium with candida famata. J Clin Microbiol 2014 Apr;52(4):1308-9 (letter).


  1. Dudley JC, Gurda GT, Tseng LH, Anderson DA, Chen G, Taube JM, Gocke CD, Eshleman JR, Lin MT. Tumor cellularity as a quality assurance measure for accurate clinical detection of BRAF mutations in melanoma. Mol Diagn Ther. 2014 Aug;18(4):409-18.
  2. Henderson LB, Applegate CD, Wohler E, Sheridan MB, Hoover-Fong J, Batista DA. The impact of chromosomal microarray on clinical management: a retrospective analysis. Genet Med. 2014 Sep;16(9):657-64.
  3. Lee RW, Bodurtha J, Cohen J, Fatemi A, Batista D. Deletion 12p12 involving SOX5 in two children with developmental delay and dysmorphic features. Pediatr Neurol 2013 Apr;48(4):317-20.
  4. Lin MT, Mosier SL, Thiess M, Beierl KF, Debeljak M, Tseng LH, Chen G, Yegnasubramanian S, Ho H, Cope L, Wheelan SJ, Gocke CD, Eshleman JR. Clinical Validation of KRAS, BRAF and EGFR Mutation Detection using Next Generation Sequencing. Am J Clin Pathol 2014 June;141(6):856-66.
  5. Ning Y, Slovak ML, Schultz RA, Gojo I, Baer MR. Cryptic chromosome abnormalities in a patient with mixed phenotype acute leukemia. Leuk Lymphoma 2014 Mar;55(3):680-2.
  6. Olson MT, Harrington C, Beierl K, Chen G, Thiess M, O'Neill A, Taube J, Zeiger MA, Lin MT, Eshleman JR. BRAF pyrosequencing analysis aided by a lookup table. Am J Clin Pathol 2014 May;141:639-47.
  7. Tseng LH, Tang JL, Haley L, Beierl K, Gocke CD, Eshleman JR, Lin MT. Microsatellite instability confounds engraftment analysis of hematopoietic stem-cell transplantation. Appl Immunohistochem Mol Morphol 2014 Jul;22(6):416-20.


  1. Ahsan S, Raabe EH, Haffner MC, Vaghasia A, Warren KE, Quezado M, Ballester LY, Nazarian J, Eberhart CG, Rodriguez FJ. Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma. Acta Neuropathol Commun 2014 Jun 3;2(1):59.
  2. Andrilopoulou E, Ellis CL, Crain BJ. 63-year-old woman with dysphonia, dysphagia, and sleep apnea. Brain Pathol 2014 Jul;24(4):423-4.
  3. Batra VV, Mines M, Rodriguez FJ. Diagnostic Review of Neurofibromatosis Type 1. Path Case Reviews 2013 Mar/Apr;19(2):57-65.
  4. Blue ME, Wilson M, Beaty CA, George TJ, Arnaoutakis GJ, Haggerty KA, Jones M, Brawn J, Manmohan S, Lange MS, Johnston MV, Baumgartner WA, Troncoso JC. Brain injury in canine models of cardiac surgery. J Neuropathol Exp Neurol 2014 Dec;73(12):1134-43.
  5. Codispoti K, Mosier S, Ramsey R, Lin MT, Rodriguez FJ. Genetic and Pathologic Evolution of Early Secondary Gliosarcoma. Brain Tumor Pathol 2014 Jan;31(1):40-6.
  6. Ding D, Lim KS, Eberhart CG. Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres. Acta Neuropathol Commun 2014 Mar 31;2(1):31.
  7. Fayzullina A, Martin LJ. Skeletal muscle DNA damage precedes spinal motor neuron DNA damage in a mouse model of Spinal Muscular Atrophy (SMA). PLoS One. 2014 Mar;9(3):e93329.
  8. Ho CY, Troncoso JC, Knox D, Stark W, Eberhart CG. Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients. Brain Pathol 2014 Jan;24(1):25-32.
  9. Iacono D, Resnick SM, O'Brien R, Zonderman AB, An Y, Pletnikova O, Rudow G, Crain B, Troncoso JC. Mild cognitive impairment and asymptomatic Alzheimer Disease subjects: equivalent beta-amyloid and tau loads with divergent cognitive outcomes. J Neuropathol Exp Neurol 2014 Apr;73(4):295-304.
  10. Mahairaki V, Ryu J, Peters A, Chang Q, Li T, Park TS, Burridge PW, Talbot CC Jr, Asnaghi L, Martin LJ, Zambidis ET, Koliatsos VE. Induced pluripotent stem cells from familial Alzheimer's disease patients differentiate into mature neurons with amyloidogenic properties. Stem Cells Dev. 2014 Dec 15;23(24):2996-3010.
  11. Martin LJ, Semenkow S, Hanaford A, Wong M. The mitochondrial permeability transition pore regulates Parkinson's disease development in mutant â•̚â–ÂÂÂÂÂÂ’-synuclein transgenic mice. Neurobiol Aging 2014 May;35:1132-52.
  12. Orr BA, Gallia GL, Dogan A, Rodriguez FJ. IgA/kappa-restricted crystal storing histiocytosis involving the central nervous system characterized by proteomic analysis. Clin Neuropathol 2014 Jan-Feb;33(1):23-8.
  13. Rodriguez FJ, Raabe EH. mTOR: a new therapeutic target for pediatric low-grade glioma? CNS Oncol 2014 Mar;3(2):89-91.
  14. Rodriguez EF, Sepah YJ, Jang HS, Ibrahim M, Nguyen QD, Rodriguez FJ. Cytologic features in vitreous preparations of patients with suspicion of intraocular lymphoma. Diagn Cytopathol. 2014 Jan;42(1):37-44.
  15. Rodriguez FJ, Tihan T, Lin D, McDonald W, Nigro J, Feuerstein B, Jackson S, Cohen K, Burger PC. Clinicopathologic Features of Pediatric Oligodendrogliomas. Am J Surg Pathol 2014 Aug;38(8):1058-70.
  16. Rossi SL, Mahairaki V, Zhou L, Song Y, Koliatsos VE. Remodeling of the piriform cortex after lesion in adult rodents. Neuroreport. 2014 Sep 10;25(13):1006-12.
  17. Ryu J, Horkayne-Szakaly I, Xu L, Pletnikova O, Leri F, Eberhart C, Troncoso JC, Koliatsos VE. The problem of axonal injury in the brains of veterans with histories of blast exposure. Acta Neuropathol Commun. 2014 Nov;2(1):153.
  18. Vizcaíno MA, Caccamo DV, Fox E, Rodriguez FJ. Pleomorphic xanthoastrocytoma: report of two cases with unconventional clinical presentations. Clin Neuropathol 2014 Nov/Dec;33(6):380-7.


  1. AlWadani S, Robinson S, Myers R, Akpek EK, Eberhart CG. No increase in IgG4-positive plasma cells in limbal Rosai-Dorfman disease. Cornea 2014 Aug;33(8):844-7.
  2. Asnaghi L, Alkatan H, Mahale A, Othman M, Alwadani S, Al-Hussain H, Jastaneiah S, Yu W, Maktabi A, Edward DP, Eberhart CG. Identification of multiple DNA copy number alterations including frequent 8p11.22 amplification in conjunctival squamous cell carcinoma. Invest Ophthalmol Vis Sci. 2014 Dec 9;55(12):8604-13.
  3. Asnaghi L, Lin MH, Lim KS, Lim KJ, Tripathy A, Wendeborn M, Merbs SL, Handa JT, Sodhi A, Bar EE, Eberhart CG. Hypoxia promotes uveal melanoma invasion through enhanced notch and MAPK activation. PlosOne 2014 Aug28;9(8):e105372.
  4. Cameron JD, Rodriguez FJ, Rushing E, Horkayne-Szakaly I, Eberhart C. An 80-year experience with optic nerve glioma cases at the Armed Forces Institute of Pathology: evolution from museum to molecular evaluation suggests possibe interventions in the cellular senescence and microglial pathways (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 2014;112:11-25.
  5. Rajaii F, Asnaghi L, Enke R, Merbs SL, Handa JT, Eberhart CG. The demethylating agent 5-Aza reduces the growth, invasiveness, and clonogenicity of uveal and cutaneous melanoma. Invest Ophthalmol. Vis Sci 2014;55(10):6178-86.
  6. Rajan Kd A, Burris C, Iliff N, Grant M, Eshleman JR, Eberhart CG. DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma. Am J Ophthalmol 2014 Mar;157(3):640-7.e1-2.


  1. Asch-Kendrick RJ, Samols MA, Lilo MT, Subhawong AP, Sharma R, Illei PB, Argani P, Cimino-Mathews A. NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas. J Clin Pathol 2014 Sep;67(9):768-71.
  2. Belchis DA. Cancer: it's all in the family. Pathol Case Revs 2014 Mar/Apr;19(2):41-2.
  3. Belchis DA. Lymphangioleiomyomatosis is a systemic disorder related to mutated tuberous sclerosis complex. Pathol Case Revs 2014 Mar/Apr;19(2):101-5.
  4. Bishop JA. Editorial: Capturing human papillomavirus status: utilizing liquid-phase HPV assays on FNAs of metastatic head and neck cancers. J Am Soc of Cytopathol 2014 Jul-Aug;3(4):171-2.
  5. Bishop JA. Non-squamous variants of human papillomavirus-related head and neck carcinoma. Diagn Histopathol 2014 Aug;20(8):301-7.
  6. Bishop JA, Antonescu CR, Westra WH. SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract. Am J Surg Pathol. 2014 Sep;38(9):1282-9.
  7. Belchis D, Cowan M, Mortman K, Rezvani B. Adenocarcinoma arising in an extralobar sequestration: a case report and review of the literature. Lung Cancer 2014 Apr;84(1):92-5.
  8. Bishop JA, Montgomery EA, Westra WH. Use of p40 and p63 immunohistochemistry and human papillomavirus testing as ancillary tools for the recognition of head and neck sarcomatoid carcinoma and its distinction from benign and malignant mesenchymal processes. Am J Surg Pathol. 2014 Feb;38(2):257-64.
  9. Bishop JA, Yonescu R, Batista D, Warnock GR, Westra WH. Glandular odontogenic cysts (GOCs) lack MAML2 rearrangements: a finding to discredit the putative nature of GOC as a precursor to central mucoepidermoid carcinoma. Head Neck Pathol 2014 Sep;8(3):287-90.
  10. Bishop JA, Yonescu R, Batista D, Yemelyanova A, Ha PK, Westra WH. Mucoepidermoid carcinoma does not harbor transcriptionally active high risk human papillomavirus even in the absence of the MAML2 translocation. Head Neck Pathol 2014 Sep;8(3):298-302.
  11. Cimino-Mathews A, Sharma R, Illei PB, Vang R, Argani P. A subset of malignant phyllodes tumors express p63 and p40: a diagnostic pitfall in breast core needle biopsies. Am J Surg Pathol. 2014 Dec;38(12):1689-96.
  12. Ellis CL, Eble JN, Subhawong AP, Martignoni G, Zhong M, Ladanyi M, Epstein JI, Netto GJ, Argani P.
  13. Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage. Mod Pathol 2014 Jun;27(6):875-86.
  14. Gonzalez-Roibon N, Faraj SF, Munari E, Bezerra SM, Albadine R, Sharma R, Argani P, Allaf ME, Netto GJ. Comprehensive profile of GATA binding protein 3 immunohistochemical expression in primary and metastatic renal neoplasms. Hum Pathol 2014 Feb;45(2):244-8.
  15. Holmes BJ, Westra WH. The expanding role of cytopathology in the diagnosis of HPV-related squamous cell carcinoma of the head and neck. Diagn Cytopathol 2014 Jan;42(1):85-93.
  16. Lee S, Han JS, Chang A, Ross HM, Montironi R, Yorukoglu K, Lane Z, Epstein JI. Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: a study of 7 cases. Hum Pathol 2013 Mar;44(3):427-31.
  17. Poling JS, Ma XJ, Bui S, Luo Y, Koch WM, Westra WH. Human papillomavirus (HPV) status of non-tobacco related squamous cell carcinomas of the lateral tongue. Oral Oncol 2014 Apr;50(4):306-10.
  18. Poling JS, Tsangaris TN, Argani P, Cimino-Mathews A. Frozen section evaluation of breast carcinoma sentinel lymph nodes: a retrospective review of 1,940 cases. Breast Cancer Res Treat 2014 Nov;148(2):355-61.
  19. Smith NE, Deyrup AT, Mariño-Enriquez A, Fletcher JA, Bridge JA, Illei PB, Netto GJ, Argani P. VCL-ALK Renal cell carcinoma in children with sickle-cell trait: the eighth Sickle-cell Nephropathy? Am J Surg Pathol 2014 Jun;38(6):858-63.
  20. Smith NE, Illei PB, Allaf M, Gonzalez N, Morris K, Hicks J, Demarzo A, Reuter VE, Amin MB, Epstein JI, Netto GJ, Argani P. t(6;11) renal cell carcinoma (RCC): expanded immunohistochemical profile emphasizing novel RCC markers and report of 10 new genetically confirmed cases. Am J Surg Pathol 2014 May;38(5):604-14.
  21. Tilson MP, Bishop JA. Utility of p40 in the differential diagnosis of small round blue cell tumors of the sinonasal tract. Head Neck Pathol 2014 Jun;8(2):141-5
  22. Tilson MP, Gallia GL, Bishop JA. Among sinonasal tumors, CDX-2 immunoexpression is not restricted to intestinal-type adenocarcinomas. Head Neck Pathol 2014 Mar;8(1):59-65
  23. Westra WH. Detection of human papillomavirus (HPV) in clinical samples: evolving methods and strategies for the accurate determination of HPV status of head and neck carcinomas. Oral Oncol 2014 Sep;50(9):771-9.
  24. Xing M, Liu R, Liu X, Murugan AK, Zhu G, Zeiger MA, Pai S, Bishop J. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol. 2014 Sep 1;32(25):2718-26


  1. Chen I, Cummings V, Fogel JM, Marzinke MA, Clarke W, Connor MB, Griffith S, Buchbinder S, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Wheeler DP, Mayer KH, Koblin BA, Eshleman SH. Low-level Viremia early in HIV infection. J Acquir Immune Defic Syndr 2014 Dec 1;67(4):405-8.
  2. Coates TJ, Kulich M, Zelaya CE, Celantano DD, Chariyalertsak S, Chingono A, Gray G, Mbwambo JKK, Morin FS, Richter L, Sweat M, van Rooven H, McGrath N, Fiamma A, Laeyendecker O, Piwowar-Manning E, Szerekes G, Donnell D, Eshleman SH. Outcomes from NIMH Project Accept (HPTN 043): A cluster-randomized trial of community mobilization, mobile HIV testing, post-test support services, and real-time performance feedback. Lancet Global Health 2014 May;2:e267-e277.
  3. Cousins MM, Konikoff J, Laeyendecker O, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Wheeler D, Justman JE, Hodder SL, Quinn TC, Brookmeyer R, Eshleman SH. HIV diversity as a biomarker for HIV incidence estimation: including a high resolution melting diversity assay in a multi-assay algorithm. J Clin Microbiol 2014 Jan;52(1):115-21.
  4. Cousins MM, Konikoff J, Sabin D, Khaki L, Longosz AF, Laeyendecker O, Celum C, Buchbinder SP, Seage GR III, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Wheeler D, Justman JE, Hodder SL, Quinn TC, Brookmeyer R, Eshleman SH. A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation. PLoS One 2014 Jun 26;9(6):e101043.
  5. Frank SM, Oleyar MJ, Ness PM, Tobian AA. Reducing unnecessary preoperative Blood orders and costs by implementing an updated institution-specific maximum surgical blood order schedule and a remote electronic blood release system. Anesthesiology 2014 Sep;121(3):501-9.
  6. Grabowski MK, Gray RH, Serwadda D, Kigozi G, Gravitt PE, Nalugoda F, Reynolds SJ, Wawer MJ, Watya S, Quinn TC, Tobian AAR. High risk human papillomavirus viral load and persistence among HIV-negative and HIV-positive men. Sex Transm Infect 2014 Jun;90(4):337-43.
  7. Kacker S, Frick KD, Gaydos CA, Tobian AAR. Male circumcision cost-effective articles ignore methodological problems and ethical concerns - reply. JAMA Pediatr 2013;167:198-200.
  8. Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, Tobian AAR. Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients. Transfusion 2014 Jan;54(1):86-97.
  9. Kacker S, Ness PM, Savage WJ, Frick KD, Shirey RS, King KE, Tobian AA. Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease. Transfusion. 2014 Aug;54(8):2034-44.
  10. Katz LM, Tobian AAR. Ebola virus disease, transmission risk to laboratory personnel and pretransfusion testing. Transfusion Dec 2014;54:3247-51.
  11. Marzinke MA, Clarke W, Wang L, Cummings V, Liu TY, Piwowar-Manning E, Breaud A, Griffith S, Buchbinder S, Shoptaw S, Del Rio C, Magnus M, Mannheimer S, Fields SD, Mayer KH, Wheeler DP, Koblin BA, Eshleman SH, Fogel JM. Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. Clin Infect Dis 2014 Jan;58(1):117-20.
  12. Moore R, Blankson JN, Eshleman SH. Failure to identify HIV-infected individuals in a clinical trial using a single HIV rapid test for screening. HIV Clin Trials 2014 Mar;15(2):62-8.
  13. Morris BJ, Tobian AA. Circumcision is a religious/cultural procedure, not a medical procedure-reply. JAMA Pediatr 2014 Mar 1;168(3):294.
  14. Pagano MB, Murinson BB, Tobian AAR, King KE. Efficacy of therapeutic plasma exchange for treatment of stiff-person syndrome. Transfusion 2014 July;54(7):1851-6.
  15. Piwowar-Manning E, Fogel JM, Laeyendecker O, Wolf S, Cummings V, Marzinke M, Clarke W, Breaud A, Wendel S, Wang L, Swanson P, Hackett J, Jr., Mannheimer S, del Rio C, Kuo I, Harawa NT, Koblin BA, Moore R, Blankson JN, Eshleman SH. Failure to identify HIV-infected individuals in a clinical trial using a single HIV rapid test for screening. HIV Clin Trials. 2014 Mar-Apr;15(2):62-8.
  16. Redd AD, Tobian AAR. The death of HIV long-term non-progression? Lancet HIV 2014 Oct;1:e8-e9.
  17. Savage WJ, Hamilton R, Tobian AAR, Milne G, Kaufman RM, Savage JH, Borge D, Ness PM. Defining risk factors and presentation of allergic reactions to platelet transfusion. J Allergy Clin Immunol 2014 Jun;133(6):1772-5.e9.
  18. Tobian AAR, Fuller AK, Uglik K, Tisch DJ, Borge PD, Benjamin RJ, Ness PM, King KE. The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment. Transfusion. 2014 Jun;54(6):1523-9.
  19. Tobian AA, Gaydos C, Gray RH, Kigozi G, Serwadda D, Quinn N, Grabowski MK, Musoke R, Ndyanabo A, Nalugoda F, Wawer MJ, Quinn TC. Male circumcision and Mycoplasma genitalium infection in female partners: a randomised trial in Rakai, Uganda. Sex Transm Infect 2014 Mar;90(2):150-4.
  20. Tobian AA, Kacker S, Quinn TC. Male circumcision: a globally relevant but under-utilized method for the prevention of HIV and other sexually transmitted infections. Annu Rev Med 2014 Jan;65:293-306.
  21. Tobian AAR, Quinn TC. Prevention of syphilis: another positive benefit for male circumcision. Lancet Glob Health 2014 Nov;2(11):e623-4.